Evidence map›Paper›PMID 39122982›Full record

Trial reportSports medicine (Auckland, N.Z.)2024

The Effects of a Novel Sodium Bicarbonate Ingestion System on Repeated 4 km Cycling Time Trial Performance in Well-Trained Male Cyclists.

Lewis A Gough, S Andy Sparks

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Sports medicine (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lewis A GoughHuman Performance and Health Research Group, Birmingham City University, Birmingham, B15 3TN, UK. lewis.gough@bcu.ac.uk.ORCID 0000-0003-1115-7559
S Andy SparksMaurten AB, Gothenburg, Sweden.ORCID 0000-0003-0910-2225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA novel sodium bicarbonate (SB) product has come to market named the "Bicarb System" (M-SB; Maurten AB, Gothenburg, Sweden). It claims to minimise gastrointestinal (GI) discomfort whilst still improving exercise performance.

aimTo investigate the effects of M-SB ingestion on repeated 4 km cycling time trials (TT1 and TT2) in well-trained male cyclists.

methodsThe study recruited ten well-trained cyclists (maximal oxygen uptake (

resultsPerformance in TT1 was faster in the M-SB condition compared with TT1 in CON (- 5.1 s; p = 0.004) and PLA (- 3.5 s; p < 0.001). In TT2, performance was also significantly faster in the M-SB condition compared with CON (- 4.4 s; p = 0.018) or PLA (- 4.1 s; p = 0.002). Total aggregated GI symptoms were generally low and not significantly different between PLA and the M-SB conditions for a range of symptoms.

conclusionsThe ingestion of M-SB improves repeated 4 km cycling TT performance and the recovery of acid-base balance between bouts, whilst causing minimal GI discomfort.

Indexed as

Athletic PerformanceBicyclingCross-Over StudiesOxygen ConsumptionSodium BicarbonateAdultDouble-Blind MethodHumansMaleYoung AdultSodium Bicarbonate

Identifiers

PMID39122982
PMCPMC11608388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.